Dimed S.A. Distribuidora de Medicamentos - Asset Resilience Ratio
Dimed S.A. Distribuidora de Medicamentos (PNVL3) has an Asset Resilience Ratio of 7.83% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check PNVL3 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Dimed S.A. Distribuidora de Medicamentos's Asset Resilience Ratio has changed over time. See PNVL3 net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Dimed S.A. Distribuidora de Medicamentos's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Dimed S.A. Distribuidora de Medicamentos stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$0.00 | 0% |
| Short-term Investments | R$286.73 Million | 7.83% |
| Total Liquid Assets | R$286.73 Million | 7.83% |
Asset Resilience Insights
- Limited Liquidity: Dimed S.A. Distribuidora de Medicamentos maintains only 7.83% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Dimed S.A. Distribuidora de Medicamentos Industry Peers by Asset Resilience Ratio
Compare Dimed S.A. Distribuidora de Medicamentos's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AstraZeneca PLC
MX:AZNN |
Drug Manufacturers - General | 0.03% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.48% |
|
Organon & Co
NYSE:OGN |
Drug Manufacturers - General | 4.46% |
|
Virbac SA
PA:VIRP |
Drug Manufacturers - General | 0.23% |
|
AstraZeneca PLC
LSE:AZN |
Drug Manufacturers - General | 0.10% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
Drug Manufacturers - General | 0.46% |
Annual Asset Resilience Ratio for Dimed S.A. Distribuidora de Medicamentos (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Dimed S.A. Distribuidora de Medicamentos.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.70% | R$410.05 Million ≈ $80.46 Million |
R$3.83 Billion ≈ $751.62 Million |
+4.56pp |
| 2024-12-31 | 6.15% | R$207.59 Million ≈ $40.73 Million |
R$3.38 Billion ≈ $662.72 Million |
-1.57pp |
| 2023-12-31 | 7.72% | R$237.48 Million ≈ $46.60 Million |
R$3.08 Billion ≈ $603.86 Million |
+2.14pp |
| 2022-12-31 | 5.58% | R$152.52 Million ≈ $29.93 Million |
R$2.73 Billion ≈ $536.29 Million |
-3.03pp |
| 2021-12-31 | 8.61% | R$205.00 Million ≈ $40.22 Million |
R$2.38 Billion ≈ $467.21 Million |
-11.01pp |
| 2020-12-31 | 19.62% | R$430.63 Million ≈ $84.50 Million |
R$2.19 Billion ≈ $430.58 Million |
+15.68pp |
| 2019-12-31 | 3.95% | R$57.67 Million ≈ $11.32 Million |
R$1.46 Billion ≈ $286.53 Million |
+1.49pp |
| 2018-12-31 | 2.46% | R$24.58 Million ≈ $4.82 Million |
R$1.00 Billion ≈ $196.29 Million |
-2.08pp |
| 2017-12-31 | 4.54% | R$43.09 Million ≈ $8.46 Million |
R$950.17 Million ≈ $186.44 Million |
+3.48pp |
| 2016-12-31 | 1.05% | R$8.62 Million ≈ $1.69 Million |
R$820.97 Million ≈ $161.09 Million |
+0.03pp |
| 2015-12-31 | 1.02% | R$7.73 Million ≈ $1.52 Million |
R$759.97 Million ≈ $149.12 Million |
-1.38pp |
| 2014-12-31 | 2.40% | R$17.26 Million ≈ $3.39 Million |
R$719.27 Million ≈ $141.13 Million |
+0.52pp |
| 2013-12-31 | 1.88% | R$11.28 Million ≈ $2.21 Million |
R$599.89 Million ≈ $117.71 Million |
-1.93pp |
| 2012-12-31 | 3.81% | R$19.09 Million ≈ $3.75 Million |
R$500.82 Million ≈ $98.27 Million |
-8.16pp |
| 2009-12-31 | 11.97% | R$39.88 Million ≈ $7.83 Million |
R$333.08 Million ≈ $65.36 Million |
+11.71pp |
| 2008-12-31 | 0.26% | R$716.00K ≈ $140.49K |
R$275.75 Million ≈ $54.11 Million |
-4.66pp |
| 2007-12-31 | 4.92% | R$12.47 Million ≈ $2.45 Million |
R$253.46 Million ≈ $49.73 Million |
-2.78pp |
| 2006-12-31 | 7.70% | R$18.03 Million ≈ $3.54 Million |
R$234.29 Million ≈ $45.97 Million |
+0.74pp |
| 2005-12-31 | 6.96% | R$15.13 Million ≈ $2.97 Million |
R$217.51 Million ≈ $42.68 Million |
-1.01pp |
| 2004-12-31 | 7.96% | R$14.33 Million ≈ $2.81 Million |
R$179.97 Million ≈ $35.31 Million |
-4.76pp |
| 2003-12-31 | 12.72% | R$21.88 Million ≈ $4.29 Million |
R$172.02 Million ≈ $33.75 Million |
-1.24pp |
| 2002-12-31 | 13.96% | R$20.27 Million ≈ $3.98 Million |
R$145.21 Million ≈ $28.49 Million |
-4.04pp |
| 2001-12-31 | 18.00% | R$28.17 Million ≈ $5.53 Million |
R$156.51 Million ≈ $30.71 Million |
+2.73pp |
| 2000-12-31 | 15.27% | R$22.56 Million ≈ $4.43 Million |
R$147.79 Million ≈ $29.00 Million |
-- |
About Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.